Evercore ISI raised the firm’s price target on Ventas to $50 from $48 and keeps an In Line rating on the shares. Heading into Q4 healthcare REIT earnings season, the firm raised its targets on four stocks in the group, reflecting slightly higher targeted forward AFFO multiples.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on VTR: